Suppr超能文献

万古霉素浸泡移植物可降低 ACL 重建后感染性关节炎的发生率:系统评价和荟萃分析的结果。

Vancomycin-soaking of the graft reduces the incidence of septic arthritis following ACL reconstruction: results of a systematic review and meta-analysis.

机构信息

Department of Trauma and Orthopaedic Surgery, Cologne Merheim Medical Centre, Witten/Herdecke University, Ostmerheimer Strasse 200, 51109, Cologne, Germany.

Department of Orthopaedic Surgery, University of Pittsburgh-UPMC Rooney Sports Complex, 3200 S Water St, Pittsburgh, PA, 15203, USA.

出版信息

Knee Surg Sports Traumatol Arthrosc. 2020 Apr;28(4):1005-1013. doi: 10.1007/s00167-019-05353-1. Epub 2019 Jan 17.

Abstract

PURPOSE

(1) To compare the incidence of post-operative septic arthritis following anterior cruciate ligament reconstruction (ACLR) between patients receiving routine pre-operative intravenous (IV) prophylaxis only intravenous (IV) infection prophylaxis and patients receiving additional graft-soaking in a vancomycin solution (5 mg/ml) perioperatively. (2) To review the literature regarding effects of graft-soaking in vancomycin solutions on outcomes, complication rates and tendon properties in ACLR.

METHODS

To identify studies pertaining to routine pre-operative IV prophylaxis and additional usage of intra-operative vancomycin-soaked grafts in primary ACLR, the Cochrane Library, SCOPUS and MEDLINE were searched till June 2018 for English and German language studies of all levels of evidence following the PRISMA guidelines. Additionally, all accepted abstracts at the ESSKA 2018, ISAKOS 2017, AGA 2017 and AOSSM 2017 meetings were screened. Data regarding the incidence of septic arthritis were abstracted and combined in a meta-analysis. Data including outcome scores, complication rates and in vitro analyses of tendon properties were collected and summarized descriptively.

RESULTS

Upon screening 785 titles, 8 studies were included. These studies examined 5,075 patients following ACLR and followed from 6 to 52 weeks post-operatively. Of those 2099 patients in the routine pre-operative IV prophylaxis group, 44 (2.1%) cases of early septic arthritis were reported. In contrast, there were no reports of septic arthritis following ACLR in 2976 cases of vancomycin-soaked grafts. The meta-analysis yielded an odds ratio of 0.04 (0.01-0.16) favouring the addition of intra-operative vancomycin-soaking of grafts. Across all available studies, no differences in clinical outcome (i.e. incidence of ACL revision, IKDC score, Tegner score), biomechanical tendon properties, or cartilage integrity between patients with and without vancomycin-soaked grafts were identified.

CONCLUSION

The incidence of septic arthritis following ACLR can be reduced dramatically by vancomycin-soaking the grafts intra-operatively prior to graft passage and fixation. Within the limitation confines of this study, intra-operative graft-soaking in vancomycin appears to be a safe and effective method to reduce the incidence of septic arthritis following ACLR. Still, it remains debatable if the available data facilitate the recommendation for a universal application of vancomycin-soaking for all ACLR patients or if it should be reserved for patients at risk, including the use hamstring tendons, revision cases and in the presence of medical preconditions.

LEVEL OF EVIDENCE

Level IV, systematic review of Level III and Level IV studies.

摘要

目的

(1)比较仅接受常规术前静脉(IV)预防用药和另外在围手术期接受万古霉素溶液(5mg/ml)浸泡移植物的患者,在前交叉韧带重建(ACLR)后发生术后脓毒性关节炎的发生率。(2)回顾关于 ACLR 中万古霉素溶液浸泡移植物对结局、并发症发生率和肌腱特性的影响的文献。

方法

为了确定与 ACLR 中常规术前 IV 预防用药和另外术中使用万古霉素浸泡移植物相关的研究,我们按照 PRISMA 指南,在 Cochrane 图书馆、SCOPUS 和 MEDLINE 上检索了截至 2018 年 6 月的所有证据水平的英语和德语文献,并对 ESSKA 2018、ISAKOS 2017、AGA 2017 和 AOSSM 2017 会议上所有接受的摘要进行了筛选。我们提取并汇总了关于脓毒性关节炎发生率的资料,并进行了荟萃分析。收集并描述了包括结局评分、并发症发生率和肌腱特性的体外分析等数据。

结果

在筛选了 785 篇标题后,纳入了 8 项研究。这些研究共纳入了 5075 例 ACLR 后患者,随访时间为术后 6 至 52 周。在常规术前 IV 预防用药组的 2099 例患者中,报告了 44 例(2.1%)早期脓毒性关节炎病例。相比之下,在 2976 例万古霉素浸泡移植物的 ACLR 患者中,没有报告发生脓毒性关节炎。荟萃分析得出的比值比为 0.04(0.01-0.16),有利于术中添加万古霉素浸泡移植物。在所有可获得的研究中,未发现使用和未使用万古霉素浸泡移植物的患者之间在临床结局(即 ACL 翻修、IKDC 评分、Tegner 评分)、生物力学肌腱特性或软骨完整性方面存在差异。

结论

通过在移植物穿过和固定之前术中浸泡万古霉素,可以显著降低 ACLR 后脓毒性关节炎的发生率。在本研究的限制范围内,术中移植物浸泡万古霉素似乎是一种安全有效的方法,可降低 ACLR 后脓毒性关节炎的发生率。然而,目前仍存在争议,即现有数据是否支持对所有 ACLR 患者普遍应用万古霉素浸泡,还是仅应用于存在风险的患者,包括使用腘绳肌腱、翻修病例以及存在医学前提条件的患者。

证据水平

IV 级,对 III 级和 IV 级研究的系统评价。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验